|
...
Novacea is utilizing the technology supporting this patent to develop DN-101 for the treatment of various types of cancer. DN-101 is newly formulated pill that contains high amounts of calcitriol, a naturally occurring hormone and the biologically active form of vitamin D. Novacea has the exclusive worldwide rights to OHSU's technology for high-dose pulse administration of calcitriol...
NOTE: All illustrations and photos
have been removed from this article.

More articles from BIOTECH Patent News
Children's Medical Center obtains United States patent.(patented stabl..., March 01, 2003 Henkel obtains United States patent.(enzyme capable of hydrolytically ..., March 01, 2003 Xenova obtains United States patent.(has patented a mutant virus)(Brie..., March 01, 2003 Calgene obtains United States patent.(Brief Article), March 01, 2003 University of North Texas obtains United States patent.(Brief Article), March 01, 2003
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|